Related Experiment Videos
[Clinical efficacy of cefmetazole in intraabdominal infection]
Abstract:
A number of different organisms can be isolated from intraabdominal infection. The most common are aerobic Gram-negative bacilli. Anaerobes are not unusual. From June 1989 to January 1990, Cefmetazole was administered to 23 patients with intraabdominal infection at Veterans General Hospital-Taipei. There were six patients with spontaneous bacterial peritonitis, five biliary tract infection, five liver abscesses, five with pelvic inflammatory disease, one acute ruptured appendicitis and another intraabdominal abscess. In addition, ten patients had sepsis. Clinical response was satisfactory in 21 (91.3%) of 23 patients, and the microbiological eradication rate was 90% (36/40). One patient with Streptococcus and Bacteroides oralis liver abscess relapsed after organism eradication. Therapy failed in a case with Pseudomonas aeruginosa and Bacteroides fragilis infection. This study showed Cefmetazole to be an effective and safe antibiotic for treatment of intraabdominal infection.
Insights
Cefmetazole effectively treated intraabdominal infections in 91.3% of patients. This antibiotic demonstrated a 90% microbiological eradication rate, proving safe and effective for common bacterial pathogens.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Context:
- Intraabdominal infections involve diverse microorganisms, frequently aerobic Gram-negative bacilli and anaerobes.
- The study was conducted from June 1989 to January 1990 at Veterans General Hospital-Taipei.
- Patient cohort included various intraabdominal infections such as spontaneous bacterial peritonitis, biliary tract infections, liver abscesses, pelvic inflammatory disease, appendicitis, and intraabdominal abscesses, alongside sepsis.
Purpose:
- To evaluate the clinical efficacy and safety of Cefmetazole in treating intraabdominal infections.
- To assess the microbiological eradication rates associated with Cefmetazole therapy.
Summary:
- Cefmetazole was administered to 23 patients diagnosed with intraabdominal infections.
- A satisfactory clinical response was observed in 21 out of 23 patients (91.3%).
- The microbiological eradication rate reached 90% (36/40), with noted treatment failures in complex cases involving Pseudomonas aeruginosa and Bacteroides fragilis.
Impact:
- Cefmetazole is confirmed as an effective and safe antibiotic option for managing intraabdominal infections.
- The findings support the use of Cefmetazole in clinical practice for susceptible bacterial infections.
- Further research may explore Cefmetazole's role in specific challenging intraabdominal infection scenarios.